• Market Crumbs

FICO Introduces New Credit Measure


Image via Avery Evans on Unsplash

FICO introduced the FICO Score in 1989. The FICO score has since become the de facto measure for measuring an individual's creditworthiness, with 90% of top lenders using it to make billions of credit-related decisions each year.


Once the coronavirus hit the U.S., the Consumer Financial Protection Bureau (CFPB) noticed an alarming uptick in the number of complaints by consumers. The CFPB saw a noticeable jump in the number of complaints relating to mortgages and credit cards mentioning the keyword "coronavirus."


"In March and April 2020, the Bureau’s Office of Consumer Response received approximately 36,700 and 42,500 complaints, respectively – the highest monthly complaint volumes in the Bureau’s history," the CFPB said.


This may not seem like much of a big deal, but can be interpreted as a leading indicator signaling credit scores could be deteriorating.


As a result, FICO introduced a new credit measure yesterday—the FICO Resilience Index, which will complement the FICO Score and "helps lenders, borrowers, and investors make more informed and precise decisions in assessing risk during rapidly changing economic cycles."


The FICO Resilience Index will take into account similar metrics, such as credit usage, payment history, number of accounts, credit history and current balances, to determine a borrower's ability to withstand a period of economic disruption. The Index will rank borrowers on a scale of 1-99, with 1-44 being more resilient and 70-99 being very sensitive to shifting economic conditions.


The FICO Resilience Index is a result of research conducted by FICO on more than 70 million consumer credit files from the Great Recession, which found that those with lower FICO Scores paid their credit obligations under double-digit unemployment and low consumer confidence.


Using the new FICO Resilience Index will benefit both lenders and borrowers, by enabling credit to better flow during periods of economic disruption. The tool is designed to provide insight into "latent risk" that is not evident in a strong economy but shows up during downturns.


"It turns out there are tens of millions of consumers that have lower FICO scores, below 700, that do relatively well in a recession," FICO Scores executive vice president Jim Wehmann said. "For the very first time, we can help lenders and consumers identify those who are going to be more sensitive to the downturn and those that are going to be just fine."


FICO will initially distribute the FICO Resilience Index scores to lenders that are already using FICO Scores. FICO is also planning to enable consumers to view their FICO Resilience Index score so they can determine how they can improve it.


With various lenders already tightening credit standards amid the coronavirus, hopefully this new measure from FICO will prevent consumers who can weather deteriorating economic conditions from being cut off from borrowing.


Leftover Crumbs

  • Pending home sales surge. U.S. pending home sales jumped 44.3% in May from the prior month, according to the National Association of Realtors. May's increase marks the largest monthly increase since the data began in 2001. Despite May's increase, pending home sales are still 5.1% lower than the same period a year earlier. "This has been a spectacular recovery for contract signings, and goes to show the resiliency of American consumers and their evergreen desire for homeownership," NAR's chief economist Lawrence Yun said.

  • CEOs see slow recovery. The Business Roundtable, which is composed of CEOs at some of America's largest companies, released its second quarter report showing most CEOs expect the impact of the coronavirus to last until at least the end of 2021. Almost a third of the CEOs polled believe the effects could last beyond 2021. The Business Roundtable’s CEO Economic Outlook Survey fell to 34.3 in the second quarter, which is the lowest reading since the second quarter of 2009.

  • Gilead prices remdesivir. Gilead Sciences announced the price of its coronavirus treatment drug remdesivir will be $3,120 for U.S. patients with private insurance. Gilead, which has been donating remdesivir to the U.S. government as part of its emergency use authorization, will begin charging for the drug in July. "At the level we have priced remdesivir and with government programs in place, along with additional Gilead assistance as needed, we believe all patients will have access," Gilead CEO Daniel O’Day said.

  • German opposition calls for inquiry. Germany's opposition party has called for a parliamentary inquiry into Wirecard's collapse. "The fact that the Bafin is waiting 15 months for a report from the FREP despite indications of irregularities is absurd," Liberal member of parliament Frank Schaeffler said. Conservative lawmaker Alexander Radwan is also calling for an investigation into the German government. "The role of the finance ministry must be examined, as reports of irregularities have been coming in for quite some time," Radwan said.

  • Coty invests in Kim Kardashian. Coty announced it has acquired a 20% stake in Kim Kardashian's makeup brand KKW for $200 million. The deal values KKW at $1 billion, which is slightly below the $1.2 billion valuation Coty gave her half sister Kylie Jenner's makeup company last year when it acquired a majority stake for $1.2 billion. The deal, which is expected to close in the third quarter, will see KKW develop skincare, haircare, personal care and nail products.